Trials / Completed
CompletedNCT05277428
Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1
A Randomized, Double-blind, Placebo-controlled, Parallel-design Clinical Study to Evaluate the Irritable Bowel Syndrome Symptoms Improving Effect and Safety of Lactobacillus Plantarum APsulloc 331261(GTB1)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Amorepacific Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the effects of daily supplementation of L. plantarum APsulloc 331261(GTB1TM) on improvement of IBS symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | GTB1 | 2 capsule/day |
| DIETARY_SUPPLEMENT | Placebo | 2 capsule/day |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2020-12-31
- Completion
- 2022-01-29
- First posted
- 2022-03-14
- Last updated
- 2022-05-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05277428. Inclusion in this directory is not an endorsement.